DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mononine (Coagulation Factor IX Human) - Drug Interactions, Contraindications, Overdosage, etc

 
 



DRUG INTERACTIONS

MONONINE drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

CONTRAINDICATIONS

Known hypersensitivity to mouse protein is a contraindication to Mononine®.

REFERENCES

  1. Zauber NP, Levin J. Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of Factor IX or fresh frozen plasma (FFP). Medicine (Baltimore) 56(3):213-24, 1977.
  2. Smith KJ, Thompson AR. Labeled Factor IX Kinetics in Patients with Hemophilia-B. Blood 58(3):625-629, 1981.
  3. Kim HC, McMillan CW, White GC, Bergman GE, Horton MW, Saidi P. Purified Factor IX Using Monoclonal Immunoaffinity Technique: Clinical Trials in Hemophilia B and Comparison to Prothrombin Complex Concentrates. Blood 79(3):568-575, 1992.
  4. Warrier I, Kasper CK, White II GC, Shapiro AD, Bergman GE, the Mononine® Study Group. Safety of high doses of a monoclonal antibody-purified factor IX concentrate. Am J Hematol 49:92-94, 1995.
  5. Shapiro AD, Ragni MV, Lusher JM, Culbert S, Koerper MA, Bergman GE, Hannan MM. Safety and Efficacy of Monoclonal Antibody Purified Factor IX Concentrate in Previously Untreated Patients with Hemophilia B. Thrombosis and Haemostasis 75:30-35, 1996.
  6. Davis HM, Nash DW, Clymer MD, Frigo ML, Bergman GE. Lack of immune response to mouse IgG in previously untreated haemophilia A and haemophilia B patients treated with monoclonal antibody purified factor VIII and factor IX preparations. Haemophilia 3(2):102-107, April 1997.
  7. Kim HC, Matts L, Eisele J, Czachur M, Saidi P. Monoclonal Antibody Purified Factor IX - Comparative Thrombogenicity to Prothrombin Complex Concentrate. Seminars in Hematology 28 (Suppl. 6 to no. 3):15-20, July 1991.
  8. Aledort LM: Factor IX and Thrombosis. Scand J Haematology Suppl. 30:40, 1977.
  9. Cederbaum AI, Blatt PM, Roberts HR. Intravascular coagulation with use of human prothrombin complex concentrates. Ann Intern Med 84:683-687, 1976.
  10. Kurczynski E, Lusher JM, Pitel P, Shapiro AD, Bergman GE, the Mononine® Study Group. Safety and efficacy of monoclonal antibody-purified factor IX concentrate for management of bleeding and surgical prophylaxis in previously treated children with hemophilia B. Int J Ped Hemat/Oncol 2:211-216, 1995.
  11. Kasper CK, Dietrich SL. Comprehensive Management of Hemophilia. Clin Haematol 14(2):489-512, 1985.
  12. Johnson AJ, Aronson DL, Williams WJ. Preparation and clinical use of plasma and plasma fractions. Chap 167 in Hematology 3rd Edition, Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Eds.), McGraw Hill Book Co. New York: pp 1563-1583, 1983.

Manufactured by:
CSL Behring LLC
Kankakee, IL 60901 USA

US License No. 1767
US Patent No. 5,055,557

Revised January, 2007
13925-04

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017